| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/16/2006 | US20060034765 MRI method for measuring tumor hemodynamic parameters in the presence of contrast agent extravasation |
| 02/16/2006 | US20060034764 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/16/2006 | US20060034763 Therapeutic use of resveratrol for hyperglycemia |
| 02/16/2006 | US20060034762 Method for measuring skin absorbability |
| 02/16/2006 | US20060034761 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
| 02/16/2006 | CA2576820A1 Method for measuring dynamics of self-assembling systems of biological molecules in vivo and uses for discovering or evaluating therapeutic agents |
| 02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/15/2006 | EP1624936A1 Cns chloride modulation and uses thereof |
| 02/15/2006 | EP1624902A1 Methods of producing carbon-13 labeled biomass |
| 02/15/2006 | EP1087793B1 Material for differently modifying the optical properties of different cells and device for applying this material |
| 02/15/2006 | CN1735802A Time discrimination optics imaging method and equipment used for part biological tissues of animal body |
| 02/15/2006 | CN1733315A Method for making animal model for research of liver/gallbladder diseases and its medicine and application thereof |
| 02/15/2006 | CN1733309A Process for preparing driving target-directional carrier of folic acid compound mediated |
| 02/15/2006 | CN1732864A Apparatus for testing drug sensitization and its application in drug sensitization test |
| 02/14/2006 | US6998513 Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use |
| 02/14/2006 | US6998107 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography |
| 02/14/2006 | US6998106 Radioconjugation of internalizing antibodies |
| 02/14/2006 | CA2375385C Propargyl phenyl ether a2a receptor agonists |
| 02/14/2006 | CA2269072C Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/09/2006 | WO2006014381A2 Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies |
| 02/09/2006 | WO2006013227A2 METHYLAMINE RISKS and TREATMENT WITH N-DERIVATIVES OF HYPERACTIVITY, DEPRESSION AND ALCOHOLISM |
| 02/09/2006 | WO2005113786A3 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 02/09/2006 | WO2005046563A3 Particules d’oxyde metallique magnetique pour l’irm dans les pathologies impliquant des proteinases |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060029609 administering drug biological conjugates used for the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
| 02/09/2006 | US20060029597 IgA antibody protein as a cytotoxic drug |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/09/2006 | US20060029550 detecting the presence of small intestinal bacterial overgrowth (SIBO) in a human subject having at least one symptom associated with a suspected diagnosis |
| 02/09/2006 | US20060029549 Determining the degradation rate of a protein or peptide in an individual by administering 2H or 18O labeled water to incorporate the label in the protein and detecting (mass spectrometry) incorporation of the label in a bodily tissue or fluid; collagen, hormones, apolipoproteins, albumin, cloning factor |
| 02/09/2006 | US20060029548 Methods of diagnosing, monitoring and treating pulmonary diseases |
| 02/09/2006 | US20060029547 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 02/09/2006 | US20060029546 Materials and methods for identifying anti-schizophrenic agents |
| 02/09/2006 | DE102004020542A1 New perylene-based dye compounds useful e.g. for preparing acetal and metals and as fluorescence dyes or pigments in: glue colors, watercolors, colors for inkjet printer, printing inks, inks or lacquers as vat dyes for e.g. paper or jute |
| 02/09/2006 | CA2830939A1 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 02/09/2006 | CA2587248A1 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 02/09/2006 | CA2572638A1 Methods and compositions for treating obesity |
| 02/08/2006 | EP1622938A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 02/08/2006 | EP1622649A2 Apparatus and method for examining an object by means of elastically scattered x-ray radiation and contrast agent |
| 02/08/2006 | EP1622647A1 Vitronectin receptor antagonist compounds and their use in the preparation of radiopharmaceuticals |
| 02/08/2006 | EP1109795B1 Thiazoline acid derivatives |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | CN1732173A High pure phthalein derivative and process for preparing the same |
| 02/08/2006 | CN1730102A Oral cavity squamous-cell carcinoma external cancerization model |
| 02/07/2006 | US6996433 Imageable biopsy site marker |
| 02/07/2006 | US6995641 Hyperpolarized gas containers, solenoids, transport and storage devices and associated transport and storage methods |
| 02/07/2006 | US6995260 Carboranylporphyrins and uses thereof |
| 02/07/2006 | US6995136 Peptide fragments of murine epidermal growth factor as laminin receptor targets |
| 02/07/2006 | US6995019 Fluorescent isothiocyanate (fitc) sinistrin, its production and use |
| 02/02/2006 | WO2006012639A2 Method of diagnosing, monitoring and treating pulmonary diseases |
| 02/02/2006 | WO2006012140A1 Carboranylporphyrins and uses thereof |
| 02/02/2006 | WO2006011811A2 Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process |
| 02/02/2006 | WO2006011810A2 Mr imaging method for the discrimination between healthy and tumour tissue |
| 02/02/2006 | WO2006011007A1 Combination anticancer therapy and pharmaceutical compositions therefore |
| 02/02/2006 | WO2005098428A3 Method and system for screening compounds for muscular and/or neurological activity in animals |
| 02/02/2006 | WO2005005626A8 Yellow fever mosquito deoxyribonucleoside kinases and its use |
| 02/02/2006 | WO2004089190A3 Methods and probes for identifying vulnerable plaque |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060026694 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 02/02/2006 | US20060025713 Magnetic particle-based therapy |
| 02/02/2006 | US20060024662 Methods for magnetic resonance imaging |
| 02/02/2006 | US20060024236 Bowel preparation for virtual colonoscopy |
| 02/02/2006 | US20060024234 Protein markers for pharmaceuticals and related toxicity |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | US20060024231 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface |
| 02/02/2006 | DE10350484B4 Verfahren und Vorrichtung zur Markierung von Proteinen Method and apparatus for labeling proteins |
| 02/02/2006 | CA2587019A1 Combination anticancer therapy and pharmaceutical compositions therefore |
| 02/02/2006 | CA2576202A1 Mr imaging method for the discrimination between healthy and tumour tissue |
| 02/02/2006 | CA2575601A1 Methods for producing compositions comprising hyperpolarized 13c-pyruvate |
| 02/02/2006 | CA2575473A1 Radicals and their use as paramagnetic agents in a dnp process |
| 02/02/2006 | CA2573565A1 Method of diagnosing, monitoring and treating pulmonary diseases |
| 02/02/2006 | CA2572287A1 Carboranylporphyrins and uses thereof |
| 02/01/2006 | EP1620564A2 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 02/01/2006 | EP1620135A1 In vivo imaging using peptide derivatives |
| 02/01/2006 | EP1509202A4 Novel high viscosity embolizing compositions comprising prepolymers |
| 02/01/2006 | CN1729180A Piperazinyl and diazapanyl benzamides and benzthioamides |
| 02/01/2006 | CN1729020A Medium for contrast enhancement or convenience for ultrasonic, endoscopic, and other medical examinations |
| 02/01/2006 | CN1727894A Method for measuring titer of multi-glycosides of triperygium wilfordii |
| 02/01/2006 | CN1727008A Gas bearing activator of dry powder in use for diagnosing and/or treating thrombus |
| 02/01/2006 | CN1727007A Method of thalidomide for effective interventing oral cancer in animal model |
| 02/01/2006 | CN1727006A Method of thalidomide for effective intervening oral cancer in animal model |
| 02/01/2006 | CN1727005A Method for building animal model of forming thrombus of deep vein in traumatic limbs and trunk of rat |
| 01/31/2006 | US6993375 Tissue site markers for in vivo imaging |
| 01/31/2006 | US6992107 (photodynamic therapy); branched alkyl and substituted benzyl ALA esters are precursors to in vitro porphyrin formation upon illumination; enhanced tumor selectivity, improved uptake, reduced pain sensation when administered; in vitro diagnosis kit |
| 01/31/2006 | US6992093 Method of inhibiting lipofibroblast to myofibroblast transdifferentiation |
| 01/31/2006 | US6991778 Use of dendrimers polyl-functionalized with nitroxide groups as contrast enhancing agents in MRI imaging of joints and injectable compositions comprising them |
| 01/31/2006 | US6991777 Methods for in vivo evaluation of physiological conditions and/or organ or system function including methods to evaluate cardiopulmonary disorders such as chronic heart failure using polarized 129 Xe |
| 01/31/2006 | US6991776 Halogenated xanthene or halogenated xanthene derivative; cancer treatment |
| 01/31/2006 | US6991775 Peptide-based multimeric targeted contrast agents |
| 01/26/2006 | WO2006009994A1 Method of determining performance of an antiperspirant composition |
| 01/26/2006 | WO2006009919A2 Improved efficacy of immunotherapy by integrating diagnostic with therapeutic methods |
| 01/26/2006 | WO2006009696A2 Anticoagulant contrast media |
| 01/26/2006 | WO2006009022A1 Liposome-containing x-ray radiopaque dye and process for producing the same |
| 01/26/2006 | WO2005102396A3 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 01/26/2006 | WO2005097208A3 Tissue oxygenation measurements |
| 01/26/2006 | WO2005094903A3 Contrast agents for magnetic resonance imaging |
| 01/26/2006 | WO2005077343A3 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 01/26/2006 | WO2005072780A3 Cellular labeling for nuclear magnetic resonance techniques |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019344 C-erbB-2 external domain: gp75 |